Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, International, Adaptive, Open-label, Repeated Administration Pharmacokinetic Study of Bilastine in Children From 2 to <12 Years of Age With Allergic Rhinoconjunctivitis or Chronic Urticaria

NCT01081574 is registered in ClinicalTrials.gov with Faes Farma, S.A. as lead sponsor.

NCT NCT01081574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01081574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, International, Adaptive, Open-label, Repeated Administration Pharmacokinetic Study of Bilastine in Children From 2 to <12 Years of Age With Allergic Rhinoconjunctivitis or Chronic Urticaria
Lead sponsor
Faes Farma, S.A.
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2010
Completion date
June 30, 2012
Enrollment
36 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis, chronic urticaria